Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Rocha, F L ^a   Carmo, E C ^a   Roque, F R ^a   Hashimoto, N Y ^a   Rossoni, L V ^a   Frimm, C ^a   Aneas I ^a   Negrao C E ^a   Krieger, J E ^a   Oliveira, E M ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratory of Biochemistry   (Brazil)

Author keywords

Cardiac hypertrophy; Collagen; Renin angiotensin system; Ventricular function

Indexed keywords

ANABOLIC AGENT; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYPROLINE; LOSARTAN; NANDROLONE DECANOATE; STEROID;

AEROBIC EXERCISE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE RELAXATION; HEART RATE; HEART VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SWIMMING; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; WISTAR RAT;

EID: 36849067573     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01251.2006     Document Type: Article

References (46)

1. Backer MA, Horvath SM. Influence of water temperature on oxygen uptake by swimming rats. J Appl Physiol 19: 1215-1218, 1964.
2. Barton PA, Chretien C, Lau AH. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients. Clin Nephrol 58: 38-46, 2002.
3. Bergman I, Loxley R. New spectrophotometric method for the determination of proline in tissue hydrolyzates. Anal Chem 42: 702-706, 1970.
4. Beutel A, Bergamaschi CT, Campos RR. Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats. J Steroid Biochem Mol Biol 93: 43-48, 2005.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102: 1388-1393, 2000.
7. Brilla CG, Maisch B, Weber KT. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. Clin Investig 71: S35-S41, 1993.
8. Brilla CG, Reams GP, Maisch B, Weber KT. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J 14: 57-61, 1993.
9. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26: 809-820, 1994.
10. Brilla CG. Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc Res 47: 1-3, 2000.
11. Busatto VC, Cicilini MA, Mill JG. Increased angiotensin-converting enzyme activity in the left ventricle after infarction. Braz J Med Biol Res 30: 679-687, 1997.
12. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
13. Cunha TS, Moura MJ, Bernardes CF, Tanno AP, Marcondes FK. Vascular sensitivity to phenylephrine in rats submitted to anaerobic training and nandrolone treatment. Hypertension 46: 1010-1015, 2005.
14. De Piccoli B, Giada F, Benettin A, Sartoti F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med 12: 408-412, 1991.
15. Di Bello V, Giorgi D, Bianchi M, Bertini A, Caputo MT, Valenti G, Furioso O, Alessandri L, Paterni M, Giust C. Effects of anabolic-androgenic steroids on weight-lifters myocardium: an ultrasonic video-densitometric study. Med Sci Sports Exerc 31: 514-521, 1999.
16. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 53: 105-108, 1984.
17. Evangelista FS, Brum PC, Krieger JE. Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz J Med Biol Res 36: 1751-1759, 2003.
18. Fineschi V, Riezzo I, Centini F, Silingardi E, Licata M, Beduschi G, Karch SB. Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic finding in two fatal cases of bodybuilders. Int J Legal Med 15: 1-6, 2005.
19. Gunja-Smith Z, Lin J, Woessner JF Jr. Changes in desmosine and pyridinoline crosslinks during rapid synthesis and degradation of elastin and collagen in the rat uterus. Matrix 9: 21-27, 1989.
20. Higaki J, Aoki M, Morishita R, Kida I, Taniyama Y, Tomita N, Yamamoto K, Moriguchi A, Kaneda Y, Ogihara T. In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. Arterioscler Thromb Vasc Biol 20: 428-434, 2000.
21. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney PA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104: 346-351, 2001.
22. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, Fujii N, Miyazaki H, Matsuda M, Yamaguchi I. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281: R2029-R2036, 2001.
23. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455, 1979.
24. Kochakian CD, Robertson E, Bartlett MN. Sites and nature of protein anabolism stimulated by testosterone propionate in the rats. Am J Physiol 163: 332-346, 1950.
25. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 12: 1135-1141, 1991.
26. Kuipers H, Wijnen JA, Hartgens F, Willems SM. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver function in body builders. Int J Sports Med 12: 413-18, 1991.
27. Legros T, McConneall D, Murry T, Edavettal M, Racey-Burns LA, Shepherd RE, Burns AH. The effects of 17α-methyltestosterone on myocardial function in vitro. Med Sci Sports Exerc 32: 897-903, 2000.
28. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 24: 313-340, 2003.
29. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptor mediates hypertrophy in cardiac myocytes. Circulation 98: 256-261, 1998.
30. Masonis AE, McCarthy MP. Direct effects of the androgenic/anabolic steroid stanozolol and 17 alpha-methyltestosterone on benzodiazepine binding to the gamma-aminobutyric acid(a) receptor. Neurosci Lett 189: 35-38, 1995.
31. Medeiros A, Oliveira EM, Gianolla R, Casarini DE, Negrão CE, Brum PC. Swimming training increases cardiac vagal activity and induces cardiac hypertrophy in rats. Braz J Med Biol Res 37: 1909-1917, 2004.
32. Nieminen MS, Ramo MP, Viitasalo M, Heikkila P, Karjalainen J, Mantyssari M, Heikkila J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 17: 1576-1583, 1996.
33. Nottin S, Nguyen LD, Terbah M, Obert P. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol 97: 912-915, 2006.
34. Oliveira EM, Krieger JE. Chronic β-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol 520: 135-141, 2005.
35. Oliveira EM, Santos RAS, Krieger JE. Standardization of the fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Braz J Med Biol Res 33: 755-764, 2000.
36. Schaible T, Malhotra A, Ciambrone GJ, Scheuer J. Chronic swimming reverses cardiac dysfunction and myosin abnormalities in hypertensive rats. J Appl Physiol 60: 1435-1441, 1986.
37. Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR. Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab 89: 4863-4872, 2004.
38. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41: 1-15, 1998.
39. Tagarakis CV, Bloch W, Hartmann G, Hollmann W, Addicks K. Anabolic steroids impair the exercise induced growth of the cardiac capillary bed. Int J Sports Med 21: 412-418, 2000.
40. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin type-1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 30: 1621-1627, 1997.
41. Trifunovic B, Norton GR, Duffield MJ, Avraam P, Woodiwiss AJ. An androgenic steroid decreases left ventricular compliance in rats. Am J Physiol Heart Circ Physiol 268: H1096-H1105, 1995.
42. Urhausen A, Holpes R, Kindermann W. One- and two- dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol Occup Physiol 58: 633-640, 1989.
43. Varo N, Etayo JC, Zalba G, Beaumont J, Iraburu MJ, Montiel C, Gil MJ, Monreal I, Diez J. Losartan inhibits the pos-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 17: 107-114, 1999.
44. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865, 1991.
45. Yu-Yahiro JA, Michael RH, Nasrallah DV, Schofield B. Morphological and histologic abnormalities in female and male rats treated with anabolic steroid. Am J Sports Med 17: 686-689, 1989.
46. Zaugg M, Jamali NZ, Lucchinetti E, Xu W, Alam M, Shafiq AS, Siddiqui MA. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 187: 90-95, 2001.